FAFGX | STDFX | FAFGX / STDFX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 4 years | 14 years | - |
Gain YTD | 30.017 | 33.361 | 90% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 306B | 1.01B | 30,178% |
Annual Yield % from dividends | 0.69 | 0.00 | - |
Returns for 1 year | 31.57 | 17.01 | 186% |
Returns for 3 years | -0.33 | -18.61 | 2% |
Returns for 5 years | N/A | 6.93 | - |
Returns for 10 years | N/A | 0.60 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
RAYD | 32.58 | 0.07 | +0.20% |
Rayliant Quantitative Dev Mkt Eq ETF | |||
FJAN | 45.49 | 0.02 | +0.04% |
FT Cboe Vest US Equity Buffer ETF Jan | |||
XLG | 49.67 | -0.01 | -0.02% |
Invesco S&P 500® Top 50 ETF | |||
QVMS | 28.91 | -0.28 | -0.95% |
Invesco S&P SmallCp 600 QVM Mlt-fctr ETF | |||
BOUT | 39.62 | -0.55 | -1.38% |
Innovator IBD® Breakout Opps ETF |